InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Anthony Hunt, Chief Executive Officer, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 15 open-market SEC Form 4 transactions: 1 purchase worth $248K and 14 sales worth $34.3M, reported from Sep 9, 21 to Nov 13, 25. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 13, 25 | RGENREPLIGEN CORP | SELL | 5.7K | $157.11 | $896K |
| Nov 12, 25 | RGENREPLIGEN CORP | SELL | 11.1K | $158.51 | $1.8M |
| Sep 10, 25 | RGENREPLIGEN CORP | SELL | 14.9K | $122.23 | $1.8M |
| May 15, 25 | RGENREPLIGEN CORP | SELL | 17.6K | $127.00 | $2.2M |
| Mar 17, 25 | RGENREPLIGEN CORP | SELL | 15.6K | $153.70 | $2.4M |
| Nov 21, 24 | RGENREPLIGEN CORP | SELL | 24.2K | $139.67 | $3.4M |
| Sep 10, 24 | RGENREPLIGEN CORP | SELL | 10.7K | $146.67 | $1.6M |
| Jun 14, 24 | RGENREPLIGEN CORP | BUY | 2.0K | $124.08 | $248K |
| May 21, 24 | RGENREPLIGEN CORP | SELL | 4.3K | $171.03 | $711K |
| Mar 8, 24 | RGENREPLIGEN CORP | SELL | 6.2K | $202.55 | $1.2M |
| Nov 11, 22 | RGENREPLIGEN CORP | SELL | 25.0K | $200.00 | $5.0M |
| Sep 8, 22 | RGENREPLIGEN CORP | SELL | 10.5K | $227.01 | $2.4M |
| Jul 21, 22 | RGENREPLIGEN CORP | SELL | 24.8K | $200.00 | $5.0M |
| Nov 18, 21 | RGENREPLIGEN CORP | SELL | 6.0K | $281.40 | $1.7M |
| Sep 9, 21 | RGENREPLIGEN CORP | SELL | 14.8K | $296.58 | $4.4M |